Cargando…

Malignancy rate of biopsied suspicious bone lesions identified on FDG PET/CT

PURPOSE: To determine the malignancy rate of bone lesions identified on FDG PET/CT in patients who have undergone CT-guided biopsy because of the suspicion of malignancy. METHODS: This single-centre retrospective study spanned eight consecutive years and included all patients who underwent both FDG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adams, Hugo J. A., de Klerk, John M. H., Heggelman, Ben G. F., Dubois, Stefan V., Kwee, Thomas C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865543/ https://www.ncbi.nlm.nih.gov/pubmed/26728144 http://dx.doi.org/10.1007/s00259-015-3282-4

Ejemplares similares

Clinical and FDG-PET/CT Suspicion of Malignant Disease: Is Biopsy Confirmation Still Necessary?
por: Bent, Talitha, et al.
Publicado: (2021)

Role of (18)F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis
por: Park, Soo Bin, et al.
Publicado: (2018)

Does the presence of tumor-induced cortical bone destruction at CT have any prognostic value in newly diagnosed diffuse large B-cell lymphoma?
por: Adams, Hugo J. A., et al.
Publicado: (2015)

FDG-PET/CT findings highly suspicious for COVID-19 in an Italian case series of asymptomatic patients
por: Setti, Lucia, et al.
Publicado: (2020)

Validity of negative bone biopsy in suspicious bone lesions
por: Lange, Mine B, et al.
Publicado: (2021)

The value of prebiopsy FDG-PET/CT in discriminating malignant from benign vertebral bone lesions in a predominantly oncologic population
por: Loudini, Naila, et al.
Publicado: (2020)

FDG PET/CT in carcinoma of unknown primary
por: Kwee, Thomas C., et al.
Publicado: (2009)

Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients
por: Kudura, Ken, et al.
Publicado: (2021)

FDG PET/CT and thyroid biopsy leads to neurosarcoidosis diagnosis
por: Bullock, Catherine, et al.
Publicado: (2023)

Choosing to biopsy or refer suspicious melanocytic lesions in general practice
por: Robison, Sean, et al.
Publicado: (2012)

Diagnostic performance of contrast enhanced CT and (18)F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection
por: Lee, Yun-Gyoo, et al.
Publicado: (2011)

Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma?
por: Kasalak, Ömer, et al.
Publicado: (2017)

Accuracy of CT-Guided Core-Needle Biopsy in Diagnosis of Thoracic Lesions Suspicious for Primitive Malignancy of the Lung: A Five-Year Retrospective Analysis
por: Baratella, Elisa, et al.
Publicado: (2022)

Malignant melanoma with cavitary pulmonary metastasis: Diagnostic dilemma resolved by FDG PET/CT guided biopsy
por: Chakraborty, Partha Sarathi, et al.
Publicado: (2014)

Incidental Breast Lesions Identified by (18)F-FDG PET/CT: Which Clinical Variables Differentiate between Benign and Malignant Breast Lesions?
por: Shin, Kyung Min, et al.
Publicado: (2015)

Case Reports on the Differentiation of Malignant and Benign Intratracheal Lesions by (18)F-FDG PET/CT
por: Chun, Kyung-Ah
Publicado: (2015)

On the Added Value of Baseline FDG-PET in Malignant Lymphoma
por: Quarles van Ufford, Henriette, et al.
Publicado: (2009)

Multicentre evaluation of stereotactic vacuum biopsies of mammographically indeterminate or suspicious lesions
por: Schulz-Wendtland, R, et al.
Publicado: (2002)

A Preliminary Study to Use SUVmax of FDG PET-CT as an Identifier of Lesion for Artificial Intelligence
por: Hirata, Kenji, et al.
Publicado: (2021)

Detection of Primary Malignancy and Metastases with FDG PET/CT in Patients with Cholangiocarcinomas: Lesion-based Comparison with Contrast Enhanced CT
por: Elias, Youssef, et al.
Publicado: (2016)

Traumatic myositis ossificans: multifocal lesions suggesting malignancy on FDG-PET/CT—a case report
por: Sasaki, Miho, et al.
Publicado: (2020)

Diagnostic value of (18)F-FDG PET/CT in discriminating between benign and malignant lesions of the ribs
por: Choi, Sunju, et al.
Publicado: (2022)

FDG-PET scan in patients with clinically and/or radiologically suspicious colorectal cancer recurrence but normal CEA
por: Sarikaya, Ismet, et al.
Publicado: (2007)

Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis
por: Kwee, Thomas C., et al.
Publicado: (2008)

Actinomyces israelii May Produce Vulvar Lesions Suspicious for Malignancy
por: McElroy, Jennifer Y., et al.
Publicado: (2006)

Cavitary lung lesion suspicious for malignancy reveals Mycobacterium xenopi
por: Fogla, Sumit, et al.
Publicado: (2018)

Histopathological diagnosis of small melanocytic lesions suspicious for malignant melanoma
por: Quintella, Danielle Carvalho, et al.
Publicado: (2017)

Systematic review on the value of end-of-treatment FDG-PET in improving overall survival of lymphoma patients
por: Adams, Hugo J.A., et al.
Publicado: (2019)

Is There Any Additional Benefit of Contrast-Enhanced CT as Part of Routine PET/CT Protocols for the Differentiation of Suspicious Incidental Gastrointestinal 2-Deoxy-(18)F-FDG Uptake?
por: Brendle, Cornelia Bettina, et al.
Publicado: (2013)

False positive finding from malignancy-like lesions on FDG PET/CT: case report of tuberculosis patients
por: Hutomo, Febby, et al.
Publicado: (2020)

Role of FDG-PET/CT in children with fever of unknown origin
por: Pijl, Jordy P., et al.
Publicado: (2020)

Diagnostic Ability of FDG-PET/CT in the Detection of Malignant Pleural Effusion
por: Nakajima, Reiko, et al.
Publicado: (2015)

The role of (18)F-FDG PET CT in common gynaecological malignancies
por: Narayanan, Priya, et al.
Publicado: (2017)

Colonic Malignant Melanoma: (18)F-FDG PET/CT Findings
por: Kaya, Eser, et al.
Publicado: (2018)

FDG-PET/CT in lymphoma
por: D'souza, Maria M, et al.
Publicado: (2013)

18F-FDG PET and PET/CT in the Localization and Characterization of Lesions in Patients with Ovarian Cancer
por: Caprio, M.G., et al.
Publicado: (2012)

RE: Diffusion-Weighted Magnetic Resonance Imaging: A New Approach in Imaging-Guided Biopsies of Cervical Lesions Suspicious for Malignancy
por: Guimaraes, Marcos Duarte, et al.
Publicado: (2013)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

Is it necessary for all patients with suspicious lesions undergo systematic biopsy in the era of MRI-TRUS fusion targeted biopsy?
por: Lv, Zhengtong, et al.
Publicado: (2023)

Characteristics of malignant thyroid lesions on [(18)F] fluorodeoxyglucose (FDG)-Positron emission tomography (PET)/Computed tomography (CT)
por: Nasr, Hatem, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_084f6lfeouiibutra3p27ogmme